Your browser doesn't support javascript.
loading
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
Stellato, Marco; Santini, Daniele; Verzoni, Elena; De Giorgi, Ugo; Pantano, Francesco; Casadei, Chiara; Fornarini, Giuseppe; Maruzzo, Marco; Sbrana, Andrea; Di Lorenzo, Giuseppe; Soraru, Mariella; Naglieri, Emanuele; Buti, Sebastiano; De Vivo, Rocco; Napolitano, Andrea; Vignani, Francesca; Mucciarini, Claudia; Grillone, Francesco; Roviello, Giandomenico; Di Napoli, Marilena; Procopio, Giuseppe.
Afiliação
  • Stellato M; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Santini D; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Verzoni E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.
  • Pantano F; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Casadei C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy.
  • Fornarini G; Onco-ematological Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Maruzzo M; Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
  • Sbrana A; Department of Surgical, Medical and Molecular Pathology and Critical Area Medicine, University of Pisa, Pisa, Italy.
  • Di Lorenzo G; Oncologia, Università del Molise, Campobasso, Italy.
  • Soraru M; Oncology Unit, Camposampiero General Hospital, Padova, Italy.
  • Naglieri E; Division of Medical Oncology, Istituto Tumori Bari Giovanni Paolo II-IRCCS, Bari, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • De Vivo R; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
  • Napolitano A; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Vignani F; AO Ordine Mauriziano, SCDU Oncologia, Turin, Italy.
  • Mucciarini C; U.O. Medicina Oncologica, Ospedale Ramazzini, Carpi-AUSL Modena, Carpi, Italy.
  • Grillone F; Azienda Ospedaliero-Universitario "Mater Domini", Policlinico of Catanzaro, Catanzaro, Italy.
  • Roviello G; Department of Health Sciences, University of Florence, Firenze, Italy.
  • Di Napoli M; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Napoli, Italy.
  • Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Front Oncol ; 11: 682449, 2021.
Article em En | MEDLINE | ID: mdl-34168997
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália